These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26182843)

  • 21. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JT; Mensink AJ; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    World J Biol Psychiatry; 2015 Jan; 16(1):12-21. PubMed ID: 22730901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High remission rates from an initial ultra-high risk state for psychosis.
    Simon AE; Umbricht D
    Schizophr Res; 2010 Feb; 116(2-3):168-72. PubMed ID: 19854621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
    Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
    Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic validity of the Eppendorf Schizophrenia Inventory (ESI): a self-report screen for ultrahigh risk and acute psychosis.
    Niessen MA; Dingemans PM; van de Fliert R; Becker HE; Nieman DH; Linszen D
    Psychol Assess; 2010 Dec; 22(4):935-44. PubMed ID: 21133552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The approved Italian version of the comprehensive assessment of at-risk mental states (CAARMS-ITA): Field test and psychometric features.
    Pelizza L; Paterlini F; Azzali S; Garlassi S; Scazza I; Pupo S; Simmons M; Nelson B; Raballo A
    Early Interv Psychiatry; 2019 Aug; 13(4):810-817. PubMed ID: 29696795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Arabic version of the Comprehensive Assessment of At Risk Mental States (CAARMS) in Tunisian adolescents and young adults.
    Braham A; Bannour AS; Ben Romdhane A; Nelson B; Bougmiza I; Ben Nasr S; Elkissi Y; Ben Hadj Ali B
    Early Interv Psychiatry; 2014 May; 8(2):147-54. PubMed ID: 23347425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population.
    Ising HK; Veling W; Loewy RL; Rietveld MW; Rietdijk J; Dragt S; Klaassen RM; Nieman DH; Wunderink L; Linszen DH; van der Gaag M
    Schizophr Bull; 2012 Nov; 38(6):1288-96. PubMed ID: 22516147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of a two-stage strategy using the 16-item Prodromal Questionnaire (PQ16/fPQ16) and the Comprehensive Assessment of At Risk Mental States (CAARMS) in the early detection of Ultra High Risk (UHR) patients in Lebanon: a cross-sectional pilot study.
    Mourad M; Atallah EP; Raad G; Haddad R; Richa S
    Encephale; 2024 Feb; 50(1):40-47. PubMed ID: 36717331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
    Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
    Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.
    Zhang T; Li H; Woodberry KA; Seidman LJ; Zheng L; Li H; Zhao S; Tang Y; Guo Q; Lu X; Zhuo K; Qian Z; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Schizophr Res; 2014 Feb; 152(2-3):391-9. PubMed ID: 24387999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD--Catalonia Study.
    Ochoa S; Haro JM; Torres JV; Pinto-Meza A; Palacín C; Bernal M; Brugha T; Prat B; Usall J; Alonso J; Autonell J
    Schizophr Res; 2008 Jul; 102(1-3):261-9. PubMed ID: 18495432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subjective effects of cannabis before the first psychotic episode.
    Peters BD; de Koning P; Dingemans P; Becker H; Linszen DH; de Haan L
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying youth at risk for psychosis using the Behavior Assessment System for Children, Second Edition.
    Thompson E; Kline E; Reeves G; Pitts SC; Schiffman J
    Schizophr Res; 2013 Dec; 151(1-3):238-44. PubMed ID: 24119463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up.
    Yung AR; Nelson B; Stanford C; Simmons MB; Cosgrave EM; Killackey E; Phillips LJ; Bechdolf A; Buckby J; McGorry PD
    Schizophr Res; 2008 Oct; 105(1-3):10-7. PubMed ID: 18765167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distress in relation to attenuated psychotic symptoms in the ultra-high-risk population is not associated with increased risk of psychotic disorder.
    Power L; Polari AR; Yung AR; McGorry PD; Nelson B
    Early Interv Psychiatry; 2016 Jun; 10(3):258-62. PubMed ID: 25772939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review.
    Savill M; D'Ambrosio J; Cannon TD; Loewy RL
    Early Interv Psychiatry; 2018 Feb; 12(1):3-14. PubMed ID: 28782283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Early Psychosis Screener (EPS): Item development and qualitative validation.
    Brodey BB; Addington J; First MB; Perkins DO; Woods SW; Walker EF; Walsh B; Nieri JM; Nunn MB; Putz J; Brodey IS
    Schizophr Res; 2018 Jul; 197():504-508. PubMed ID: 29254878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study.
    Nenadic I; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Schizophr Res; 2015 Feb; 161(2-3):169-76. PubMed ID: 25497442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive insight in individuals at ultra-high risk for psychosis compared to patients with first-episode psychosis and non-psychotic help-seeking youths.
    Preti A; Barbera S; Malvini L; Confalonieri L; Parabiaghi A; Magnani N; Lora A; Butteri E; Prato K; Vaggi M; Percudani M
    Asian J Psychiatr; 2022 Jul; 73():103107. PubMed ID: 35461034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.